Kathleen Sebelius - Oct 13, 2021 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Kathleen Sebelius by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Oct 13, 2021
Transactions value $
$0
Form type
4
Date filed
10/15/2021, 03:35 PM
Previous filing
Aug 27, 2021
Next filing
Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025.